http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1120412-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0206961f36808cf46dba23d76240998
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-323
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-323
filingDate 1965-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1968-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1120412-A
titleOfInvention Novel 2-aminoethylpyrrol-3-yl ketones
abstract Novel 2-aminoethylpyrrol - 3 - yl ketones of general formula <FORM:1120412/C2/1> wherein R1 is H or alkyl of 1-4 carbon atoms, phenyl, benzyl, or 2-, 3- or 4-pyridyl group, R2, R3 and R4 are alkyl, alkenyl or cycloalkyl groups of up to 8 carbon atoms, or phenyl, halophenyl, lower alkoxyphenyl, benzyl, or R3 and R4 together are an alicyclic ring of up to 8 carbon atoms, R5 is H or alkyl, alkenyl, or cycloalkyl of up to 8 carbon atoms, or phenyl, or benzyl, R6 is H or methyl, or together with R5 forms a ring containing up to 6 carbon atoms, and X and Y are H, lower alkyl, hydroxy lower alkyl, lower-acyloxyalkyl, carbamyloxy-lower alkyl or phenyl-lower alkylcycloalkyl groups, or which together form a heterocyclic ring having a maximum of 8 members, and the non-toxic acid addition salts thereof, are prepared by Mannich reaction using as starting materials pyrrol-3-yl ketones of formula <FORM:1120412/C2/2> and ammonia, or primary and secondary amines, or the compounds of the invention may be prepared in two steps by reacting pyrroles, suitably substituted, with b -halo propionyl halides, and reacting the product with ammonia, or a primary or secondary amine. Lower alkyl, acyl and alkoxy groups contain up to 5 carbon atoms. Pyrrol-3-yl ketones of the second formula above are prepared by reduction of an a -oximino ketone in the presence of a 1,3-diketone, condensation occurring during the reduction process, or by a Friedel-Craft reaction between suitably substituted pyrroles and an acyl halide. 4,5-Dimethyl-2-propyl-pyrrole is prepared by reacting ethyl butyrylacetate and 2-oximino-3butanone, reducing the resulting product with zinc dust and acetic acid to form ethyl-4,5dimethyl - 2 - propyl - pyrrole - 3 carboxylate and hydrolysing and decarboxylating this compound. Ethyl - 5 - butyl - 2,4 - dimethylpyrrole3 carboxylate is prepared by a similar method and then converted to 5-butyl-2,4-dimethyl pyrrole by hydrolysis and decarboxylation. Pharmaceutical compositions useful as tranquillizers and antidepressants, and which may be administered orally, parenterally, or rectally in the form of tablets, capsules, syrups, injectable solutions or suppositories, contain a compound of the first general formula above as the active ingredient.
priorityDate 1964-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427656446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421326788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426101432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53703261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59864918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426235255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86146963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414042261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448379541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17804644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430714671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430764763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57475673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82280069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431940222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123832072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53973346

Total number of triples: 51.